Posted: December 21, 2023
David L. McGlasson, MS, MLS(ASCP) A few months ago, I posted on LinkedIn that I noticed at recent conferences and journal articles that blood coagulation factors were sometimes referred to in Euro-Arabic numbers (E-A), 0 through 9, instead of Roman numerals.For example, “F8” was written instead of “FVIII”.And sometimes they are used interchangeably. I received…
Posted: October 24, 2023
-Contributed by Abi Kasberg, PhD Changes have arrived to the field of hepatic steatosis! In efforts to destigmatize and enhance the identification of steatotic liver diseases, several worldwide governing bodies (AASLD, EASL, and ALEH) recently came together to form a multi-stage Delphi panel that assessed, edited, and published changes to the standard nomenclature and diagnostic…
Posted: October 5, 2023
-Contributed by Abi Kasberg, PhD and Olivia Stricker, PhD Neutrophil extracellular traps (NETs) are an amazing participant of the innate immune system. In a first line of defense, neutrophils expel decondensated chromatin into the extracellular matrix to trap invading pathogens in a mechanism called NETosis. NETs are made up of DNA, histones, and granule…
Posted: September 8, 2023
David L. McGlasson, MS, MLS(ASCP) The most recent ISLH meeting was held in New Orleans, LA May 11-13, 2023. The conference had many State-of-the-Art sessions and I concentrated on the hemostasis/thrombosis presentations. On the first day, Katrien Devreese MD, PhD, Ghent University Hospital, Belgium gave an excellent presentation on the current Diagnosis of Acquired Thrombotic…
Posted: April 19, 2023
-Contributed by Abi Kasberg, PhD High levels of enthusiasm and excitement were shared at this year’s NASH-TAG meeting in Deer Valley, Utah, regarding the future of the NASH landscape. This was in large part due to the announcement of positive data from two phase 3 clinical trials for new NASH drugs: Madrigal’s Resmetirom and Intercept’s…
Posted: April 19, 2023
-Olivia Stricker, PhD Meetings are back baby! This was the first event that I have been to since the pandemic where it felt 100% back to normal. It was great to get back to it and have others there to get back to it with. In heading to Nashville, DiaPharma/I was in search of answers…
Posted: April 14, 2023
David L. McGlasson, MS, MLS(ASCP) At the recent HTRS 2023 Scientific Symposium, a lively discussion in a Plenary Session was presented titled, “Do We Dare to DOAC?” The HTRS session was moderated by Ayesha N. Zia MD, MSCS and Bethany T. Samuelson, MD, and included three presenters: Introduction to Science: Stephan Moll, MD, University of…